Abstract
A modular systems biology approach may be useful to gain a better understanding of complex cellular processes, such as cell cycle and ageing. We show in fact in this review that this approach has been successfully applied to the identification of the long sought molecular mechanism able to set the critical cell size required to enter S phase in budding yeast. It involves two sequential thresholds set by the cyclin dependent kinase inhibitors Far1 and Sic1, that cooperate in carbon source modulation of the critical cell size required to enter S phase, a hallmark of response of the cell cycle to changing growth conditions. After this initial validation, the approach is tested to extract from available literature data a blueprint of ageing in budding yeast. The blueprint newly proposes that the process of ageing is initiated at the level of the yeast cell wall, due to the increase in size of ageing mother cells. This event would result in a mechanical stress of the cell wall that generates a signaling response able to activate two interconnected major cellular responses involved in ageing: stress metabolism and chromatin remodelling. The ensuing new approach to ageing studies is described in comparison with current theories of cell ageing.
Keywords: cell cycle, ageing, systems biology, saccharomyces cerevisiae
Current Genomics
Title: Probing Control Mechanisms of Cell Cycle and Ageing in Budding Yeast
Volume: 5 Issue: 8
Author(s): L. Alberghina, M. Vai and M. Vanoni
Affiliation:
Keywords: cell cycle, ageing, systems biology, saccharomyces cerevisiae
Abstract: A modular systems biology approach may be useful to gain a better understanding of complex cellular processes, such as cell cycle and ageing. We show in fact in this review that this approach has been successfully applied to the identification of the long sought molecular mechanism able to set the critical cell size required to enter S phase in budding yeast. It involves two sequential thresholds set by the cyclin dependent kinase inhibitors Far1 and Sic1, that cooperate in carbon source modulation of the critical cell size required to enter S phase, a hallmark of response of the cell cycle to changing growth conditions. After this initial validation, the approach is tested to extract from available literature data a blueprint of ageing in budding yeast. The blueprint newly proposes that the process of ageing is initiated at the level of the yeast cell wall, due to the increase in size of ageing mother cells. This event would result in a mechanical stress of the cell wall that generates a signaling response able to activate two interconnected major cellular responses involved in ageing: stress metabolism and chromatin remodelling. The ensuing new approach to ageing studies is described in comparison with current theories of cell ageing.
Export Options
About this article
Cite this article as:
Alberghina L., Vai M. and Vanoni M., Probing Control Mechanisms of Cell Cycle and Ageing in Budding Yeast, Current Genomics 2004; 5 (8) . https://dx.doi.org/10.2174/1389202043348652
DOI https://dx.doi.org/10.2174/1389202043348652 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Aldosterone Receptor Antagonists and Cardiovascular Disease: Do We Need a Change of the Guard?
Cardiovascular & Hematological Agents in Medicinal Chemistry Role of Free Radicals and Poly(ADP-Ribose)Polymerase-1 in the Development of Spinal Cord Injury: New Potential Therapeutic Targets
Current Medicinal Chemistry Identification of New Targets for Therapy of Osteolytic Bone Disease in Multiple Myeloma
Current Drug Targets Implication of Aberrant Glycosylation in Cancer and Use of Lectin for Cancer Biomarker Discovery
Protein & Peptide Letters Heat Shock Proteins: Mediators of Atherosclerotic Development
Current Drug Targets Targeting the Toll-System in Cardiovascular Sciences
Recent Patents on Inflammation & Allergy Drug Discovery Substrates and Inhibitors of Human Multidrug Resistance Associated Proteins and the Implications in Drug Development
Current Medicinal Chemistry PEDF and Septic Shock
Current Molecular Medicine Linezolid - The First Oxazolidinone in the Treatment of Nosocomial MRSA Pneumonia
Recent Patents on Anti-Infective Drug Discovery Developmental Immunotoxicity (DIT) in Drug Safety Testing: Matching DIT Testing to Adverse Outcomes and Childhood Disease Risk
Current Drug Safety Immunomodulation of the Allergic Inflammatory Response: New Developments
Inflammation & Allergy - Drug Targets (Discontinued) Possible Role of the Extracellular Signal-Regulated Kinase (ERK) in Reward-Controlled Learning and Addiction
Current Neuropharmacology Application of 3D Biomimetic Models in Drug Delivery and Regenerative Medicine
Current Pharmaceutical Design The HGF-Met Signaling Axis: Emerging Themes and Targets of Inhibition
Current Protein & Peptide Science Erythropoietic Porphyrias: Animal Models and Update in Gene-Based Therapies
Current Gene Therapy Adenosine Deaminase in the Modulation of Immune System and its Potential as a Novel Target for Treatment of Inflammatory Disorders
Current Drug Targets Deep Learning in the Quest for Compound Nomination for Fighting COVID-19
Current Medicinal Chemistry Mangiferin – a Bioactive Xanthonoid, not only from Mango and not just Antioxidant
Mini-Reviews in Medicinal Chemistry Type I Interferons: Ancient Peptides with Still Under-Discovered Anti-Cancer Properties
Protein & Peptide Letters Pathophysiology of HIV-1 in Semen: Current Evidence for Compartmentalisation and Penetration by Antiretroviral Drugs
Current HIV Research